Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,453 | 3,573 | 1,623 | 4,968 | 8,791 |
| Receivables | N/A | 0 | N/A | 360 | 488 |
| TOTAL | $9,373 | $4,893 | $4,347 | $7,379 | $11,570 |
| Non-Current Assets | |||||
| PPE Net | 152 | 179 | 192 | 209 | 210 |
| Investments And Advances | 112 | 112 | 112 | 0 | 0 |
| Other Non-Current Assets | 590 | 698 | 940 | 0 | 236 |
| TOTAL | $854 | $989 | $1,244 | $209 | $446 |
| Total Assets | $10,228 | $5,882 | $5,591 | $7,588 | $12,016 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,139 | 3,044 | 5,059 | 4,347 | 3,748 |
| TOTAL | $5,598 | $3,523 | $5,450 | $4,347 | $3,771 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 54 | 82 | N/A | N/A | 24 |
| Other Non-Current Liabilities | 190 | 266 | 378 | 0 | 0 |
| TOTAL | $190 | $266 | $378 | $N/A | $N/A |
| Total Liabilities | $5,788 | $3,789 | $5,827 | $4,347 | $3,771 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 0 | 16,999 | 15,824 | 12,977 |
| Common Shares | 1 | 0 | 2 | 0 | 1 |
| Retained earnings | -42,329 | -37,029 | -32,687 | -27,870 | -22,736 |
| TOTAL | $4,440 | $2,093 | $-237 | $3,241 | $8,244 |
| Total Liabilities And Equity | $10,228 | $5,882 | $5,591 | $7,588 | $12,016 |